Smith & Nephew Reinstates FY21 Guidance As Q1 Sales Rise On Higher Hip Implants Sales 2021-04-29T16:40:00-04:00April 29th, 2021| share this article! , Benzinga Staff Writer April 29, 2021 12:40pm 283 Read More share this article! Related Posts This Overlooked AI Stock Is Stronger Than It Has Ever Been @themotleyfool #stocks $BIPC $BIP May 4th, 2024 This 8.3%-Yielding Dividend Stock Has Plenty of Fuel to Continue Producing Prodigious Amounts of Passive Income @themotleyfool #stocks $MPLX May 4th, 2024 How Dividend Investors Can Profit As AI Changes Everything May 4th, 2024 Wall Street Analysts Predict 1000% Upside for These 7 Penny Stocks May 4th, 2024